We are live on ! Find out more
WA1

Wimmer Associates 1 Portfolio holdings

AUM $205M
1-Year Est. Return 21.23%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+21.23%
3 Year Est. Return
+69.43%
5 Year Est. Return
+91.58%
10 Year Est. Return
+307.32%
AUM
$109M
AUM Growth
-$14K
Cap. Flow
-$4.32M
Cap. Flow %
-3.98%
Top 10 Hldgs %
25.09%
Holding
113
New
4
Increased
20
Reduced
58
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 14.23%
2 Technology 13.01%
3 Industrials 11.81%
4 Financials 9.82%
5 Consumer Staples 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VO icon
76
Vanguard Mid-Cap ETF
VO
$107B
$400K 0.37%
10,896
-240
-2% -$8.66K
BA icon
77
Boeing
BA
$175B
$386K 0.36%
1,519
+101
+7% +$23.5K
TJX icon
78
TJX Companies
TJX
$178B
$382K 0.35%
10,374
-420
-4% -$15K
NVS icon
79
Novartis
NVS
$304B
$379K 0.35%
4,929
-558
-10% -$42.1K
MRK icon
80
Merck
MRK
$326B
$362K 0.33%
5,931
+175
+3% +$10.6K
GPC icon
81
Genuine Parts
GPC
$17.9B
$354K 0.33%
3,700
VWO icon
82
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$352K 0.32%
+8,069
New +$349K
XLNX
83
DELISTED
Xilinx Inc
XLNX
$352K 0.32%
4,975
CNI icon
84
Canadian National Railway
CNI
$78.3B
$345K 0.32%
4,160
PAYX icon
85
Paychex
PAYX
$42.3B
$344K 0.32%
5,744
HD icon
86
Home Depot
HD
$343B
$341K 0.31%
2,085
-45
-2% -$6.9K
EV
87
DELISTED
Eaton Vance Corp.
EV
$332K 0.31%
6,731
DUK icon
88
Duke Energy
DUK
$101B
$314K 0.29%
3,738
GILD icon
89
Gilead Sciences
GILD
$167B
$312K 0.29%
3,854
PFE icon
90
Pfizer
PFE
$144B
$309K 0.28%
9,129
+331
+4% +$10.6K
HON icon
91
Honeywell
HON
$78.3B
$303K 0.28%
2,369
CMCSA icon
92
Comcast
CMCSA
$85.8B
$284K 0.26%
7,385
-1,119
-13% -$44.1K
DHR icon
93
Danaher
DHR
$140B
$277K 0.26%
3,643
IVW icon
94
iShares S&P 500 Growth ETF
IVW
$71.9B
$276K 0.25%
7,700
BRK.A icon
95
Berkshire Hathaway Class A
BRK.A
$1.1T
$275K 0.25%
1
VEU icon
96
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$273K 0.25%
5,175
IJR icon
97
iShares Core S&P Small-Cap ETF
IJR
$110B
$267K 0.25%
3,600
COP icon
98
ConocoPhillips
COP
$139B
$258K 0.24%
5,163
+3
+0.1% +$135
KMI icon
99
Kinder Morgan
KMI
$70.3B
$257K 0.24%
13,424
-3,346
-20% -$65.2K
UL icon
100
Unilever
UL
$144B
$252K 0.23%
3,866
-889
-19% -$57.1K

Similar funds

Wimmer Associates 1's Q3 2017 Portfolio in Review

As of Q3 2017, Wimmer Associates 1 held 113 positions worth $109M, down 0.01% from $109M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Wimmer Associates 1 withdrew a net $4.32M in Q3 2017, closing 6 positions and reducing 58 holdings. Its most notable exit was AstraZeneca, an estimated $1.47M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

Against the trend, Wimmer Associates 1 opened a new position in Nucor worth $1.32M.

  • Wimmer Associates 1's largest Q3 2017 buy was Nucor: 23,615 shares worth $1.32M.
  • Wimmer Associates 1 added most to Vanguard FTSE Developed Markets ETF in Q3 2017, an estimated $768K increase.
  • Wimmer Associates 1's biggest Q3 2017 reduction was Wells Fargo, cutting an estimated $508K.
  • Wimmer Associates 1 fully exited AstraZeneca in Q3 2017, selling an estimated $1.47M.
  • Wimmer Associates 1's ten largest holdings make up 25% of its $109M portfolio in Q3 2017.
  • Wimmer Associates 1 opened 4 new positions and closed 6 in Q3 2017.
  • Wimmer Associates 1's portfolio value fell 0.01% quarter-over-quarter to $109M.

Based on Wimmer Associates 1's 13F filing for Q3 2017, filed 14 Nov 2017.